Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Q1 2024 Kura Oncology Financial Results Conference Call. At this time, all participants are in listen-only mode.
Kura Oncology Inc. (KURA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 7,069,627 | $150,795,144 | +2% | 5.6% |
| 2. | EcoR1 Capital Oleg Nodelman | 5,806,871 | $123,860,558 | 3.13% | |
| 3. | Deerfield Management James E. Flynn | 5,411,571 | $115,428,809 | +2% | 2% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 4,786,293 | $102,091,630 | -36% | 2.8% |
| 5. | VenBio Select Advisor Kurt Von Emster | 3,850,000 | $82,120,500 | +30% | 0.95% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.50 | 50,000 | Director | 139,557 | 2023-06-16 | Filing | |
| $13.16 | 83,540 | Large Shareholder | 4,408,097 | 2018-12-21 | Filing | |
| $13.84 | 51,879 | Large Shareholder | 4,324,557 | 2018-12-19 | Filing | |
| $13.82 | 78,469 | Large Shareholder | 4,272,678 | 2018-12-18 | Filing | |
| $13.89 | 25,217 | Large Shareholder | 4,220,729 | 2018-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.15 | 2,615 | 68,979 | 2024-05-20 | Filing | ||
| $17.80 | 963 | 48,093 | 2024-01-29 | Filing | ||
| $17.80 | 761 | 49,056 | 2024-01-29 | Filing | ||
| $17.80 | 594 | 49,817 | 2024-01-29 | Filing | ||
| $17.80 | 2,053 | 68,979 | 2024-01-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,315,647 | $105,199,003 | 0% | |
| 2. | 4,037,691 | $58,061,996 | 0% | |
| 3. | 2,921,810 | $42,015,628 | 0% | |
| 4. | 2,001,754 | $28,784,934 | 0% | |
| 5. | 1,849,947 | $26,602,238 | 13.44% |
News See All
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript
Kura Oncology, Inc. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.56. Kura Oncology, Inc.
5 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the five most promising cancer stocks according to analysts.
Kura Oncology, Inc. (NASDAQ:KURA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Third Quarter 2023 Kura Oncology Inc. Earnings Conference Call. At this time, all lines are in listen-only mode.
14 Best Cancer Stocks To Buy Now
The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for a growing number of patients.
5 Best U.S. Stocks to Buy Now Under $10
Gray Television, Inc. (NYSE:GTN) is a company that operates television stations and digital platforms in the U.S. It owns or has affiliations with over 200 stations across 94 markets.
Kura Oncology, Inc. (NASDAQ:KURA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Q2 2023 Kura Oncology, Inc. Earnings Conference Call. At this time, all lines are in listen-only mode.
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Q1 2023 Kura Oncology, Inc. Earnings Conference Call. [Operator Instructions].
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Kura Oncology's Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Small-Cap Growth Stocks Hedge Funds Love
It’s been a rough year for growth stocks to say the least.
Billionaire Hedge Funds
